Certified by Founder Lodge
Pfizer
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $125,000,000
14 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend
| Company | Date | Round | Raised |
|---|---|---|---|
 Nimbus Therapeutics |
September, 13 ,2022 | Unknown | $125,000,000 |
 VitaDAO |
February, 15 ,2023 | Unknown | $4,100,000 |
 Mediar Therapeutics |
March, 15 ,2023 | Unknown | $105,000,000 |
 Flare Therapeutics |
March, 23 ,2023 | Series B | $123,000,000 |
 Vedanta Biosciences, Inc. |
April, 26 ,2023 | Unknown | $106,500,000 |
 Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
 Crossbow Therapeutics, Inc |
July, 12 ,2023 | Series A | $80,000,000 |
 CellCentric |
July, 24 ,2023 | Unknown | $25,000,000 |
 ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
 RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
 Curve Therapeutics |
February, 28 ,2024 | Series A | $51,183,495 |
 Mission Therapeutics |
March, 15 ,2024 | Unknown | $32,101,650 |
 Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
 Grey Wolf Therapeutics |
May, 23 ,2024 | Series B | $50,000,000 |
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Rapafusyn Pharmaceuticals | $28,000,000 | (Jun 25, 2024)
Upword | $3,000,000 | (Jun 25, 2024)
Daydream | $50,000,000 | (Jun 25, 2024)
BillionToOne | $130,000,000 | (Jun 25, 2024)
Wilya | $4,000,000 | (Jun 25, 2024)
